Johnson Johnson raises forecasts, estimates $2.5 billion in COVID-19 vaccine sales

Johnson Johnson raises forecasts, estimates $2.5 billion in COVID-19 vaccine sales The JJ shot, once touted as an important tool for vaccinations in hard-to-reach areas, has already delayed deliveries in the United States and Europe.

No comments:

Post a Comment